Epilepsy Clinical Trials in Rochester, Minnesota

6 studies are recruiting for epilepsy in Rochester, Minnesota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Diagnosing Epilepsy To EffeCT Change

   The purpose of this research is to address the challenges of diagnosing and long-term management of epilepsy in participants whose seizures are not well captured by standard electroencephalography (EEG) tests and who cannot use or are not able to use more standard monitoring techniques. This resear…

   Stage

   Not phased

   Ages

   18 to 75

   Site

   Mayo Clinic - Rochester, Rochester, Minnesota

   Locations

   21 in total

   Run by

   Epiminder America, Inc.

   See if you can join NCT07110337 on ClinicalTrials.gov

2. Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

   The purpose of this research is to address the challenges of correctly monitoring, managing, and diagnosing epilepsy in participants whose seizures are not well captured by standard electroencephalography (EEG) tests and who cannot use or are not able to use more standard monitoring techniques. Thi…

   Stage

   Not phased

   Ages

   18 to 75

   Site

   Mayo Clinic - Rochester, Rochester, Minnesota

   Locations

   18 in total

   Run by

   Epiminder America, Inc.

   See if you can join NCT07110454 on ClinicalTrials.gov

3. Subcortical Arousal in Perceptual Awareness

   The study consists of prospective enrollment of healthy participants and patients with epilepsy, as well as analysis of an existing data set. Healthy participants will be studied with fMRI, eye metrics and behavioral testing at Yale. Patients will be studied with intracranial thalamic and cortical …

   Stage

   Not phased

   Ages

   13 and older

   Site

   Mayo Clinic, Rochester, Minnesota

   Locations

   8 in total

   Run by

   Yale University

   See if you can join NCT06934356 on ClinicalTrials.gov

4. A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

   This is a clinical research study for an investigational drug called RAP-219 in patients with Refractory Focal Epilepsy. This study is being conducted to determine RAP-219 Long- term safety and open-label antiseizure activity in patients with Refractory Focal Epilepsy.

   Stage

   Phase 2

   Ages

   18 to 70

   Site

   Mayo Clinic, Rochester, Minnesota

   Locations

   7 in total

   Run by

   Rapport Therapeutics Inc.

   See if you can join NCT07219407 on ClinicalTrials.gov

5. Effect of Vagal Nerve Stimulation on Gastric Motor Functions

   The specific aim of this study is to compare simultaneous assessment of gastric emptying and gastric accommodation in response to a caloric meal In patients who have previously undergone activation of left cervical VNS for the treatment of medication-resistant depression. Our hypothesis is that cer…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Mayo Clinic in Rochester, Rochester, Minnesota

   Locations

   2 in total

   Run by

   Mayo Clinic

   See if you can join NCT06038929 on ClinicalTrials.gov

6. Genetic Markers of Cardiovascular Disease in Epilepsy

   Epilepsy is a common condition which affects over 3 million people in the US. Patients with uncontrolled epilepsy have a lifetime risk of sudden unexpected death (SUDEP) of 35%, which is greatest in those under 40 years of age. The exact mechanisms and causes are not understood but can be due to un…

   Stage

   Not phased

   Ages

   18 to 50

   Site

   Mayo Clinic, Rochester, Minnesota

   Run by

   Mayo Clinic

   See if you can join NCT02824822 on ClinicalTrials.gov